Jiutian Chemical Group Limited (C8R) AI Stock Analysis

• Market Cap: S$47.72M
• Dividend Yield: N/A
• Average Volume (3M): 1.87M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.02
• Revenue Growth: -60.43%
• EPS Growth: 57.93%
• Country: SG
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 70
• Industry: Chemicals
• EPS (TTM): -0.01
• Shares Outstanding: 1,988,444,000
• 10 Day Avg. Volume: 1,660,140
• 30 Day Avg. Volume: 1,874,580
• PEG Ratio: 0.03
• Price to Book (P/B): 0.68
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 1.96
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: S$0.00 ▼(-100.00%Downside)

Jiutian Chemical Group Limited's stock score is heavily influenced by its poor financial performance and valuation metrics, both scoring the lowest possible. Technical analysis also indicates weak momentum, contributing to the low overall score. The absence of earnings call insights or notable corporate events further emphasizes the company's current challenges without any positive offsetting factors.

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description

Jiutian Chemical Group Limited (C8R) is a chemical manufacturing company based in China. The company is primarily engaged in the production of dimethylformamide (DMF) and methylamine, which are essential chemicals used in a wide range of industrial applications. Jiutian Chemical serves various sectors including pharmaceuticals, agrochemicals, and electronics, offering high-quality chemical products to meet industry demands.

How the Company Makes Money

Jiutian Chemical Group Limited generates revenue through the manufacturing and sale of chemical products, specifically dimethylformamide (DMF) and methylamine. These products are used as solvents and intermediates in various industrial processes, providing essential components for the production of pharmaceuticals, agrochemicals, and other industrial goods. The company's revenue streams are primarily driven by sales contracts with manufacturers in these sectors. Additionally, Jiutian Chemical may benefit from strategic partnerships and long-term supply agreements that ensure stable demand and consistent income. By leveraging its production capabilities and focusing on high-quality chemical manufacturing, the company maintains a competitive position in the global chemical market.

Jiutian Chemical Group Limited Financial Statement Overview

Summary

Jiutian Chemical Group Limited is facing severe financial difficulties, with declining revenue, profitability, and cash flow. The income statement shows critical weaknesses in generating profits, while the balance sheet indicates moderate leverage but declining equity. Cash flow challenges further exacerbate the company's financial instability, raising concerns about its ability to sustain operations.

Income Statement

Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over the past years. The gross profit margin and net profit margin have turned negative, indicating that the company is not covering its costs. The revenue growth rate has decreased significantly, with a notable drop in total revenue from 2022 to 2023. EBIT and EBITDA margins are also negative, highlighting poor operational performance. Overall, the company's income statement presents substantial financial challenges.

Balance Sheet

The balance sheet of Jiutian Chemical Group Limited shows moderate leverage with a debt-to-equity ratio that has improved slightly over the years. However, the equity ratio has decreased, indicating a decline in the proportion of assets financed by equity. Return on Equity (ROE) has become negative due to consecutive net losses. Although cash reserves are relatively strong, the overall stability is compromised by declining equity and profitability.

Cash Flow

The cash flow situation is concerning, with free cash flow experiencing a negative growth rate and operating cash flow consistently negative over the recent years. The operating cash flow to net income ratio is unfavorable, reflecting inefficiencies in converting income to cash. Free cash flow to net income ratio is also negative, indicating cash flow issues that could impact future operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	393.13M	243.76M	598.56M	2.43B	2.17B	1.15B
Gross Profit	-147.20M	-82.26M	-260.18M	708.41M	675.62M	274.77M
EBITDA	-141.98M	-118.22M	-321.76M	696.61M	632.38M	259.93M
Net Income	-162.31M	-147.80M	-344.64M	490.50M	324.90M	173.69M
Balance Sheet
Total Assets	1.42B	1.05B	1.29B	1.99B	1.89B	1.43B
Cash, Cash Equivalents and Short-Term Investments	698.48M	400.41M	529.62M	1.11B	773.55M	259.73M
Total Debt	234.88M	289.32M	265.88M	134.64M	228.18M	344.30M
Total Liabilities	469.16M	427.02M	523.23M	764.65M	1.08B	911.93M
Stockholders Equity	948.17M	618.04M	765.84M	1.22B	816.21M	524.74M
Cash Flow
Free Cash Flow	-356.18M	-171.63M	-511.23M	424.05M	633.54M	122.69M
Operating Cash Flow	-328.39M	-81.58M	-385.65M	434.01M	655.81M	129.02M
Investing Cash Flow	-27.72M	-89.54M	-125.70M	-9.85M	-27.68M	-10.90M
Financing Cash Flow	-53.04M	32.87M	-732.00K	-95.52M	-110.89M	5.67M

Jiutian Chemical Group Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 0.05 is Positive, neither overbought nor oversold. The STOCH value of -66.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$10.29B	9.96	-0.15%	2.86%	2.14%	-32.15%
C8R	41 Neutral	S$47.72M	―	-21.30%	―	-60.43%	57.93%
C05		S$36.07M	5.85	-17.75%	3.16%	―	―
5DS		S$53.32M	6.75	14.57%	2.50%	―	―
A55		S$52.84M	130.00	0.37%	3.50%	―	―
BEI		S$52.98M	23.80	3.88%	5.03%	―	―
Y8E		S$29.78M	―	-10.42%	―	―	―

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Extends Long-Stop Date for Synthetic Ammonia Project

Jiutian Chemical Group Limited has announced a third extension of the Long-Stop Date for its Framework Agreement and Synthetic Ammonia Project Transfer Agreement with Anyang Chemical Industry Group Co., Ltd. The extension, now set for December 31, 2025, is necessary to fulfill certain conditions precedent. The company has not reported significant developments since its last update and advises shareholders to exercise caution with their securities.

Jiutian Chemical Group Holds Twentieth AGM

Jiutian Chemical Group Limited held its Twentieth Annual General Meeting at Voco Orchard Singapore, where the Board of Directors and key company officials were present. The meeting was chaired by Executive Director Mr. Lee Chee Seng and addressed shareholder questions regarding resolutions, with responses published on SGXNet prior to the meeting.

Jiutian Chemical Reports Revenue Decline Amid Market Challenges

Jiutian Chemical Group Limited reported a significant decline in revenue for the first quarter of 2025, with an 83% drop compared to the same period last year, due to weak demand and increased competition. Despite this, the company managed to reduce its net loss by 56% through effective cost control and streamlined operations, reflecting a strategic focus on long-term efficiency and competitiveness.

Jiutian Chemical Group Publishes Shareholder Q&A Ahead of AGM

Jiutian Chemical Group Limited has announced that it has published responses to shareholder questions ahead of its 20th Annual General Meeting. This move aims to enhance transparency and engage with shareholders effectively, potentially strengthening stakeholder relations and reinforcing the company’s commitment to open communication.